vs
FirstCash Holdings, Inc.（FCFS）与PHIBRO ANIMAL HEALTH CORP（PAHC）财务数据对比。点击上方公司名可切换其他公司
FirstCash Holdings, Inc.的季度营收约是PHIBRO ANIMAL HEALTH CORP的1.3倍（$501.3M vs $373.9M），FirstCash Holdings, Inc.净利率更高（20.8% vs 7.3%，领先13.4%），FirstCash Holdings, Inc.同比增速更快（21.2% vs 20.9%），过去两年PHIBRO ANIMAL HEALTH CORP的营收复合增速更高（19.2% vs 16.9%）
FirstCash Holdings, Inc.是总部位于美国得克萨斯州沃斯堡的典当企业，在美国及拉丁美洲多地运营线下典当零售门店，为纳斯达克证券交易所公开上市企业，在美洲典当服务领域拥有成熟的业务布局与完善的运营网络。
菲宝罗动物保健公司是一家美国动物健康与矿物质营养企业，主营产品涵盖抗菌药、抗球虫药、驱虫药，以及畜禽营养补充剂、疫苗等。公司下设矿物质营养、功能材料、动物健康三大业务板块，收入主要来源于上述板块，业务遍及美国、拉美、加拿大、欧洲、中东、非洲及亚太地区。
FCFS vs PAHC — 直观对比
营收规模更大
FCFS
是对方的1.3倍
$373.9M
营收增速更快
FCFS
高出0.3%
20.9%
净利率更高
FCFS
高出13.4%
7.3%
两年增速更快
PAHC
近两年复合增速
16.9%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $501.3M | $373.9M |
| 净利润 | $104.2M | $27.5M |
| 毛利率 | — | 35.5% |
| 营业利润率 | 28.5% | 13.5% |
| 净利率 | 20.8% | 7.3% |
| 营收同比 | 21.2% | 20.9% |
| 净利润同比 | 24.7% | 762.1% |
| 每股收益（稀释后） | $2.35 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FCFSPAHC
| Q4 25 | $501.3M | $373.9M | ||
| Q3 25 | $411.0M | $363.9M | ||
| Q2 25 | $385.1M | $378.7M | ||
| Q1 25 | $371.1M | $347.8M | ||
| Q4 24 | $413.7M | $309.3M | ||
| Q3 24 | $363.1M | $260.4M | ||
| Q2 24 | $363.5M | $273.2M | ||
| Q1 24 | $366.8M | $263.2M |
净利润FCFSPAHC
| Q4 25 | $104.2M | $27.5M | ||
| Q3 25 | $82.8M | $26.5M | ||
| Q2 25 | $59.8M | $17.2M | ||
| Q1 25 | $83.6M | $20.9M | ||
| Q4 24 | $83.5M | $3.2M | ||
| Q3 24 | $64.8M | $7.0M | ||
| Q2 24 | $49.1M | $752.0K | ||
| Q1 24 | $61.4M | $8.4M |
毛利率FCFSPAHC
| Q4 25 | — | 35.5% | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | — | 29.0% | ||
| Q1 25 | — | 30.1% | ||
| Q4 24 | — | 32.9% | ||
| Q3 24 | — | 32.1% | ||
| Q2 24 | — | 31.9% | ||
| Q1 24 | — | 30.2% |
营业利润率FCFSPAHC
| Q4 25 | 28.5% | 13.5% | ||
| Q3 25 | 27.4% | 14.1% | ||
| Q2 25 | 21.1% | 8.9% | ||
| Q1 25 | 30.0% | 9.6% | ||
| Q4 24 | 26.5% | 8.3% | ||
| Q3 24 | 23.5% | 6.8% | ||
| Q2 24 | 18.2% | 6.7% | ||
| Q1 24 | 22.3% | 7.6% |
净利率FCFSPAHC
| Q4 25 | 20.8% | 7.3% | ||
| Q3 25 | 20.1% | 7.3% | ||
| Q2 25 | 15.5% | 4.5% | ||
| Q1 25 | 22.5% | 6.0% | ||
| Q4 24 | 20.2% | 1.0% | ||
| Q3 24 | 17.9% | 2.7% | ||
| Q2 24 | 13.5% | 0.3% | ||
| Q1 24 | 16.7% | 3.2% |
每股收益（稀释后）FCFSPAHC
| Q4 25 | $2.35 | $0.67 | ||
| Q3 25 | $1.86 | $0.65 | ||
| Q2 25 | $1.34 | $0.43 | ||
| Q1 25 | $1.87 | $0.51 | ||
| Q4 24 | $1.86 | $0.08 | ||
| Q3 24 | $1.44 | $0.17 | ||
| Q2 24 | $1.08 | $0.02 | ||
| Q1 24 | $1.35 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $125.2M | $74.5M |
| 总债务越低越好 | $2.2B | $624.2M |
| 股东权益账面价值 | $2.3B | $332.4M |
| 总资产 | $5.3B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.98× | 1.88× |
8季度趋势，按日历期对齐
现金及短期投资FCFSPAHC
| Q4 25 | $125.2M | $74.5M | ||
| Q3 25 | $130.2M | $85.3M | ||
| Q2 25 | $101.5M | $77.0M | ||
| Q1 25 | $146.0M | $70.4M | ||
| Q4 24 | $175.1M | $67.1M | ||
| Q3 24 | $106.3M | $89.8M | ||
| Q2 24 | $113.7M | $114.6M | ||
| Q1 24 | $135.1M | $98.7M |
总债务FCFSPAHC
| Q4 25 | $2.2B | $624.2M | ||
| Q3 25 | $2.2B | $628.0M | ||
| Q2 25 | $1.7B | $631.7M | ||
| Q1 25 | $1.7B | $635.4M | ||
| Q4 24 | $1.7B | $639.1M | ||
| Q3 24 | $1.7B | $295.2M | ||
| Q2 24 | $1.7B | $312.1M | ||
| Q1 24 | $1.5B | — |
股东权益FCFSPAHC
| Q4 25 | $2.3B | $332.4M | ||
| Q3 25 | $2.2B | $311.7M | ||
| Q2 25 | $2.1B | $285.7M | ||
| Q1 25 | $2.1B | $266.0M | ||
| Q4 24 | $2.1B | $246.8M | ||
| Q3 24 | $2.0B | $258.5M | ||
| Q2 24 | $2.0B | $256.6M | ||
| Q1 24 | $2.0B | $270.1M |
总资产FCFSPAHC
| Q4 25 | $5.3B | $1.4B | ||
| Q3 25 | $5.2B | $1.4B | ||
| Q2 25 | $4.5B | $1.4B | ||
| Q1 25 | $4.4B | $1.3B | ||
| Q4 24 | $4.5B | $1.3B | ||
| Q3 24 | $4.4B | $966.3M | ||
| Q2 24 | $4.3B | $982.2M | ||
| Q1 24 | $4.2B | $979.0M |
负债/权益比FCFSPAHC
| Q4 25 | 0.98× | 1.88× | ||
| Q3 25 | 1.01× | 2.01× | ||
| Q2 25 | 0.79× | 2.21× | ||
| Q1 25 | 0.83× | 2.39× | ||
| Q4 24 | 0.85× | 2.59× | ||
| Q3 24 | 0.87× | 1.14× | ||
| Q2 24 | 0.85× | 1.22× | ||
| Q1 24 | 0.75× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $206.6M | $19.4M |
| 自由现金流经营现金流 - 资本支出 | — | $8.3M |
| 自由现金流率自由现金流/营收 | — | 2.2% |
| 资本支出强度资本支出/营收 | — | 3.0% |
| 现金转化率经营现金流/净利润 | 1.98× | 0.70× |
| 过去12个月自由现金流最近4个季度 | — | $47.3M |
8季度趋势，按日历期对齐
经营现金流FCFSPAHC
| Q4 25 | $206.6M | $19.4M | ||
| Q3 25 | $135.8M | $9.3M | ||
| Q2 25 | $116.9M | $21.3M | ||
| Q1 25 | $126.6M | $43.2M | ||
| Q4 24 | $198.1M | $3.1M | ||
| Q3 24 | $113.1M | $12.6M | ||
| Q2 24 | $106.2M | $28.4M | ||
| Q1 24 | $122.5M | $11.4M |
自由现金流FCFSPAHC
| Q4 25 | — | $8.3M | ||
| Q3 25 | — | $-4.5M | ||
| Q2 25 | — | $8.1M | ||
| Q1 25 | — | $35.4M | ||
| Q4 24 | — | $-4.7M | ||
| Q3 24 | — | $3.0M | ||
| Q2 24 | — | $15.4M | ||
| Q1 24 | — | $1.7M |
自由现金流率FCFSPAHC
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | -1.2% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 10.2% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 5.6% | ||
| Q1 24 | — | 0.6% |
资本支出强度FCFSPAHC
| Q4 25 | — | 3.0% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 4.8% | ||
| Q1 24 | — | 3.7% |
现金转化率FCFSPAHC
| Q4 25 | 1.98× | 0.70× | ||
| Q3 25 | 1.64× | 0.35× | ||
| Q2 25 | 1.95× | 1.24× | ||
| Q1 25 | 1.51× | 2.07× | ||
| Q4 24 | 2.37× | 0.97× | ||
| Q3 24 | 1.74× | 1.81× | ||
| Q2 24 | 2.16× | 37.80× | ||
| Q1 24 | 2.00× | 1.36× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FCFS
| US Pawn Segment | $292.2M | 58% |
| Retail POS Payment Solutions | $209.8M | 42% |
PAHC
| Medicated Feed Additives And Others | $202.1M | 54% |
| Mineral Nutrition | $68.9M | 18% |
| Nutritional Specialties | $50.2M | 13% |
| Vaccines | $37.6M | 10% |
| Performance Products | $15.0M | 4% |
